Skip to main content
Download PDF

The oral phenotype and dental management in patients with maple syrup urine disease; case report and scoping review

BMC Oral Health volume 24, Article number: 362 (2024) Cite this article

Abstract

Background and objectives

The literature about oral manifestations and dental management in maple syrup urine disease (MSUD) is sparse. The aim of this report is to present a new case of MSUD with special emphasis on oral findings and to review the relevant literature.

Method

A case report of a 4-year-old boy with MSUD was described according to the CARE guidelines for describing case reports. Scoping review of relevant literature was performed, according to the PRISMA-ScR guidelines, by searching PubMed, Medline, Embase, and the grey literature for articles describing dental management and/or oral manifestations in MSUD.

Results

The initial search identified 219 articles, but only 4 met the inclusion criteria. Rampant caries and plaque induced gingivitis were the main oro-dental findings in MSUD. Other oral findings included enamel hypoplasia, skeletal abnormalities, and abnormal oral behaviors. Disease-related factors appeared to play a major role in the development of the observed oral phenotype.

Conclusion

Oral health in MSUD seems to be influenced by the reliance on semi-synthetic diet and associated neurocognitive complications. Tailored oral health promotional interventions should be included in the multidisciplinary management of patients with MSUD.

Peer Review reports

Introduction

Maple Syrup Urine Disease (MSUD) is an autosomal recessive disorder characterized by an abnormal catabolism of the branched chain amino acids [1]. The disease was first described in 1954 in four siblings with infantile brain oedema, seizures, spasticity, respiratory irregularities, and severe ketoacidosis in association with a strong maple syrup odor to the urine [2]. Later, in 1995, the accumulated materials in the urine were identified as the branched chain amino acids: isoleucine, leucine, and valine [3]. The disease therefore became known as branched-chain ketoaciduria or branched-chain ketonuria.

The abnormal catabolism of the branched chain amino acids is caused by dysfunction of an inner-mitochondrial enzyme complex known as branched-chain alpha-keto acid dehydrogenase (BCKAD) [4, 5]. Enzymatic dysfunction can be caused by various mutations in BCKDHA, BCKDHB, DBT, DLD genes located at chromosomes 19, 6, 1, and 7 respectively; these genes encode the E1α, E1 β, E2 and E3 subunits of the enzyme complex [1, 5,6,7].

The exact prevalence of MSUD is not known, but figures ranging from 1:200 to 1:185000 have been reported from different parts of the world [8, 9]. In regions with high prevalence, neonatal screening for high blood level of amino acids is routinely performed to allow early detection [7]. Nevertheless, the disease is often diagnosed at late stages, especially in developing countries and in regions where neonatal screening for MSUD is not routinely performed [10].

Currently, there are 5 recognized phenotypes of MSUD: classical, intermediate, intermittent, thiamine-responsive, and E3-deficient types (Table 1) [1, 7, 11]. Symptoms and severity of MSUD vary greatly among affected patients depending on the exact type and the amount of residual enzymatic activity. The classical type is the most common variant of MSUD and is characterized by a distinctive maple syrup odor in urine and sweat that typically appears in the first few days of neonatal life. Without intervention, the disease becomes quickly progressive and leads to brain edema and various manifestations such as irritability, lethargy, feeding difficulties, and metabolic acidosis [7, 12,13,14,15]. Neurological symptoms such as spasticity, quadriplegia, and stereotyped movements are particularly common [8, 14, 15].

Table 1 Summary of the five main types of MSUD
Full size table

Patients with MSUD require lifelong monitoring of amino acid levels and the use of protein-restricted diet rich in carbohydrates and fat and supplemented with medical amino acids formula [8, 9, 15]. In some patients, hemodialysis or hemofiltration might be needed to remove surplus amino acids, and liver transplantation might offer patients with classical MSUD an effective long-term treatment and may arrest disease progress [8, 16].

The oral health in patients with MSUD might be compromised due to the long-term use of semisynthetic diet and the associated complications such as intellectual disability, obesity, and use of medications. In fact, studies evaluating the oral health status in patients with MSUD are sparse, but increased prevalence of dental caries, dental anomalies and oral infections have been reported [17, 18]. Furthermore, dental management of patients with MSUD might be challenging especially when general anesthesia is needed to facilitate dental treatment. Here, we describe the oral and dental findings in a 4-year-old boy with classical MSUD. Furthermore, we present a scoping review to identify knowledge gaps and outline the scope of literature about oral manifestations and dental management in MSUD.

Case report

A 4-year-old boy with moderately severe intellectual disability was presented to the special care dentistry clinic regarding the complaints of toothache and sialorrhea. The parents reported that the boy became irritable, agitated, and kept flapping his face and hitting his head during the last few days. The mother reported that the boy became extremely nervous when she attempted to brush his teeth and thought that he might have toothache.

The patient was the first boy for consanguineous parents (maternal cousins) and was born at full-term normal delivery. The medical history was remarkable for moderately severe intellectual disability and generalized hypotonia secondary to MSUD that was diagnosed by a whole exome sequencing performed at the age of 4 weeks. Genetic sequencing revealed the presence of nonsense mutation in the DBT gene (NM_001918.2): c.[30G > A] p.[(trp10*)]. The boy was placed on a strict diet (BCAA protein-free food), and high in sugar and carbohydrates. The parents reported episodes of recurrent hypoglycemia that were regularly managed by bolus plain sugar administration.

General examination revealed generalized global development delay (Height of 90 cm; weight of 12 kg), unsteady gait, generalized hypotonia, and impaired expressive and receptive communication. Head and neck examination revealed microcephaly, symmetrical face without swellings or cervical lymphadenopathy, prominent eyelashes, satellite-ears, sialorrhea, and slightly protruded mandible (Fig. 1). Oral examination revealed incompetent lips, and prominent tongue thrust causing anterior open bite. The oral soft tissues were normal, but he had poor oral hygiene, plaque induced gingivitis, and early childhood caries. The lower anterior teeth showed evidence of hypocalcification involving the incisal and middle thirds (Fig. 1).

Fig. 1
figure 1

Oral findings in the patient with MSUD included, generalized dental caries involving all posterior teeth and upper anterior teeth, enamel hypoplasia involving the lower anterior teeth, hypotonia with sialorrhea

Full size image

A comprehensive treatment plan was formulated and involved dietary counseling, oral hygiene instructions, oral physiotherapy, and treatment of tooth decay. The patient was unable to tolerate dental care under local anesthesia and was scheduled for comprehensive dental care under general anesthesia. The parents were informed about the planned procedure and educated about risks and benefits, and written consent was obtained. Pre-anesthetic assessment included neurological and cardiovascular assessment. Evaluation of electrolytes and air blood gases (ABGs) revealed normal results, but the plasma level of branched chain amino acids was elevated (isoleucine 210 µM/L [normal range 26–159 µM/L]; leucine 538 µM/L [normal range 50–264 µM/L]; valine 343 µM/L [normal range 96–566 µML]. At the day of surgery, pre-operative fasting glucose test revealed mild hypoglycemia (70 mg/dl). IV access was established with lactated ringer fluid and naso-endotracheal intubation was performed uneventfully. Anesthesia was induced with sevoflurane inhalation (8%) and cysatracurium (0.15 mg/kg) and was maintained with isoflurane 2%. During surgery, which lasted for 60 min, the patient was hemodynamically stable and dextrose saline 5% was given as boluses of 500 mg twice. Blood glucose was measured twice intra-operatively and readings were comparable to pre-operative readings (73 mg/dl and 80 mg/dl). Recovery went uneventful, but during the postoperative period, the patient had an episode of hypoglycemia (48 mg/dl) and was managed by 2 g bolus of 10% dextrose saline. Dental treatment involved pulpotomy of all molar teeth with direct composite restorations, gingival prophylaxis, and fissure sealant placement. The patient was observed for 6 h during the post-operative period and there were no complications; oral intake was re-established on his BCAA protein-free food. The boy was discharged on the same day of surgery and the parents were educated regarding oral hygiene practices. Oral exercises to minimize sialorrhea were initiated and the patient was referred for dietary counseling. The patient was placed on a three-monthly follow up schedule for oral hygiene reinforcement and fluoride gel application.

Scoping review

Materials and methods

A scoping review is defined as a type of knowledge synthesis that uses a systematic and iterative approach to identify and synthesize an existing or emerging body of literature on a given topic. The main reason to perform a scoping review is to map the extent, range, and nature of the literature, as well as to determine possible gaps in the literature on a topic [19]. In the present study, we conducted a scoping review about oral manifestations and dental management in patients with MSUD. This review was conducted following the Joana Briggs Institute guidelines for scoping reviews [19]. A search of the literature was performed using PubMed, Medline, and Embase databases. In addition, the grey literature was searched using Google Scholar and cross referencing of selected articles. The key words used in the search were: (maple syrup urine disease OR branched-chain ketoaciduria OR branched-chain ketonuria) AND (oral OR dental). No time or language restrictions were applied to the database search.

Following removal of duplicates, search results were screened based on their titles and abstract to identify potentially relevant studies. Included studies were selected according to the participants, concept, and context (PCC) criteria (Table 2) [19]. Studies, regardless of the type, describing oral or dental manifestations or discussing oral health care related issues in individuals with MSUD were included in this review.

Table 2 The Participant, Concept, Context (PCC) criteria definition in the present review
Full size table

Results and discussion

An initial search of the databases and the grey literature identified a total 219 of articles. After removal of duplicates and screening of abstracts, a total of 8 articles were evaluated by reading the full text, and only 4 articles met the eligibility criteria and were included in this review (Fig. 2). Three articles were published in English. One article was published with an English abstract and a Japanese full text; the full text was translated, and relevant data were included in the analysis. Findings of the 4 included articles and the findings from our case were categorized under 3 main categories: oro-dental findings; radiographic findings; oral health issues and provision of dental care (Table 3).

Fig. 2
figure 2

Prisma flow chart for scoping review

Full size image
Table 3 Data extraction table and summary of included studies in the present review
Full size table

Oral findings

The presence of rampant caries was consistently reported in included studies. Fukushima et al., 1986 and Gazit et al., 1989 reported the presence of rampant caries in a 5-year-old girl a 14-year-old boy with classical MSUD respectively [18, 20]. Similar findings were reported in a retrospective study from Turkey where Ballikaya et al., 2021 examined 25 children and young adolescents with MSUD and identified dental caries in 72% of the cases [17]. The mean dmft score was 6.2 and dmfs was 22.26, while the mean DMFT score was 2.66 and DMFS was 5.83. Similarly, our patient demonstrated clinical evidence of early childhood caries. The occurrence of rampant caries in children with MSUD can be attributed to the reliance on semisynthetic milk during early life and to the negative effect of associated nutritional deficiency on tooth development. In addition, children with MSUD often suffer from neurological complications such as hypotonia, spasticity, lack of muscle coordination, and learning disability [1,2,3,4]. These abnormalities can increase the risk of dental caries, indirectly, by impairing the normal chewing and swallowing behaviors and affecting the ability to perform oral hygiene measures [21, 22]. The presence of enamel hypoplasia can further increase the risk of dental caries. In fact, enamel defects were reported in more than 50% of the cohort examined by Ballikaya et al., 2021, and in the patient reported by Fukushima et al., 1986 and in our patient [17, 20].

Gingivitis was also consistently reported among included studies, and variable degrees of gingival inflammation were reported in all patients from the included studies including our patient. The mean plaque index score among the cohort examined by Ballikaya et al., 2021 was 2.5 [17]. Gazit et al., 1989 described the occurrence of severe inflammatory gingival enlargement and microscopic evidence of osteomyelitis in a boy with MSUD. The authors, however, failed to provide a biomedical or metabolic explanation to the presence of severe gingival enlargement and bone and soft tissue necrosis, but argued that that chronic destructive inflammatory process in the gingiva and local factors such as poor oral hygiene, heavy calculus formation, and severely decayed teeth could have possibly caused soft tissue and bone necrosis [18].

Skeletal abnormalities reported among patients with MSUD included elongated faces, incompetent lips, crowding, small dental arches, and abnormal mandibular position (i.e. prognathism or retrognathism) [17, 18, 20, 23]. The exact cause for these skeletal abnormalities is not known, but it seems that the presence of hypotonia and lack of muscle coordination combined with soft artificial diet could be a major contributor to the observed skeletal phenotype [24,25,26,27,28].

Radiographic findings

Data about radiographic evaluation in patients with MSUD was available in two studies [17, 20]. Fukushima et al., 1986 reported no abnormal dental radiographic findings in their reported patients. However, Ballikaya et al., 2021 examined 12 patients using orthopantogram, and identified dental anomalies in 58% of the examined patients. Reported abnormalities included Turner hypoplasia, aberrant mandibular premolar, taurodontism, flattening of the mandibular condyle, hyperplasia of the coronoid process, and bifid mandibular canal [17]. It seems difficult to draw any fresh conclusion regarding radiographic findings in MSUD because of the limited number of evaluated patients and the lack of standardized radiographic assessment protocol in the study of Ballikaya et al., 2021.

Oral health issues and provision of dental care

Although the number of included studies is limited, all reported patients exhibited generalized dental caries and a variable degree of gingival inflammation. These findings suggest that dental caries and plaque induced gingivitis are the major oral health related issues in patients with MSUD. It seems difficult to adequately interpret the findings of dental caries and gingivitis in patients with MSUD because of the limited number of included patients. Nevertheless, comparing these findings with studies evaluating oral health in a relatively similar metabolic disease (i.e. phenyl ketonuria [PKU]) might provide some insight on oral health in patients with MSUD. Most studies in children with PKU have revealed a similar or lower prevalence of caries compared to healthy children [29,30,31]. A low rate of caries despite a highly cariogenic diet might result from high phenylalanine (the accumulating amino acid in PKU), which has been considered to possibly act as a factor that limits the growth of plaque microorganisms [31]. It seems that the high prevalence of dental caries in MSUD might be attributed to the oral health behaviors, diet, and concomitant diseases such as epilepsy or intellectual disorders. In fact, it was reported that intellectual performance of children with MSUD patients was significantly lower than that of a matched cohort of early treated PKU patients [32]. Oral healthcare professionals dealing with MSUD therefore should perform adequate assessment to disease-related factors that can contribute to the increased prevalence of dental caries and gingivitis such as lip incompetence, mouth breathing/tongue thrusting behaviors, hypotonia and slow chewing cycle, and abnormal swallowing pattern [24,25,26,27,28]. Furthermore, dietary assessment and counseling should be an integral part of any oral health promotional program directed at patients with MSUD.

In addition to caries and gingivitis, sialorhoea and abnormal chewing/swallowing behaviors seem to be important oral health issues in MSUD. Multidisciplinary care involving oral health education, physiotherapy, and chewing exercises should be considered essential in patients with MSUD.

Individuals with MSUD might suffer from traumatic oral and dental injuries because of associated neurological complications such as seizures, spasticity, and lack of muscle coordination. In fact, Dan et al., 2006 reported the placement of dental implant in a 19-year-old girl with MSUD who sustained avulsion of an upper anterior tooth following seizure episode [23]. Fixed prosthesis seems to be preferable in patients with MSUD to minimize the risk of aspiration associated with hypotonia, learning disability, and seizure episodes.

The provision of dental care in patients with MSUD seems to be challenging because of the presence of learning disability, the lack of muscle coordination, and the rampant dental disease. Dental care under general anesthesia therefore might be necessary. Dental care under general anesthesia was described in 3 studies [18, 20, 23]. However, details of pre-anesthetic assessment, administrations of general anesthesia, and post-operative recovery were not adequately described. Patients with strict artificial diet are more vulnerable to nutritional deficiency which might complicate the provision of dental care under general anesthesia. Pre-operative assessment should include evaluation of hemoglobin level, branched chain amino acid levels, and plasma electrolytes level. Neurological assessment of disease severity and susceptibility to seizure episode should also be considered during the pre-operative assessment. In addition, patients with MSUD, especially the very young ones, are susceptible to hypoglycemia, which was evident in our case. Therefore, regular monitoring of blood glucose level during dental treatment and in the early post-operative period is recommended.

Conclusion

Oral manifestations in MSUD are rarely reported in the literature, and solid conclusions are difficult to obtain from this review due to the small number of included articles. Nevertheless, dental caries and plaque induced gingivitis are the main oral health related issues in individuals with MSUD. Reliance on semi-synthetic diet, associated neurological complications, lack of oral hygiene practices, abnormal oral behaviors, and enamel hypoplasia seem to be the major contributing factors. Tailored oral health educational programs should be considered an integral part of the multidisciplinary management of patients with MSUD. Adequate knowledge and training are required for the proper delivery of tailored oral healthcare for individuals with special healthcare needs including those with MSUD. Furthermore, promotion campaigns for oral health in individuals with special healthcare needs are necessary to improve the awareness of parents and caregivers [33,34,35].

Further studies describing the oro-dental findings in patients with MSUD are encouraged to help better define the “oral” phenotype in this disease, to identify the major oral health related concerns, and to develop better understanding to the provision of dental care of affected patients. Areas of knowledge gap in the scope of oral health in MSUD are numerus and include the effect of the semisynthetic diet on tooth development, oral health interventions in children with MSUD, the oral phenotype in older patients, and the impact of dental diseases of MSUD on the overall health and quality of life in affected patients.

Data availability

Data are available from corresponding author on reasonable request.

References

  1. Strauss KA, Puffenberger EG, Carson VJ, Maple Syrup Urine Disease. 2006 Jan 30 [updated 2020 Apr 23]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2023.

  2. HURST -MENKESJH, CRAIG PL. A new syndrome: progressive familial infantile cerebral dysfunction associated with an unusual urinary substance. Pediatrics. 1954;14(5):462–7.

    Article  PubMed  Google Scholar 

  3. Chuang DT. Maple syrup urine disease: it has come a long way. J Pediatr. 1998;132(3 Pt 2):S17–23.

    Article  CAS  PubMed  Google Scholar 

  4. Burrage LC, Nagamani SC, Campeau PM, et al. Branched-chain amino acid metabolism: from rare mendelian diseases to more common disorders. Hum Mol Genet. 2014;23(R1):R1–8.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Ali EZ, Ngu LH. Fourteen new mutations of BCKDHA, BCKDHB and DBT genes associated with maple syrup urine disease (MSUD) in Malaysian population. Mol Genet Metab Rep. 2018;17:22–30.

    CAS  PubMed  PubMed Central  Google Scholar 

  6. Hassan SA, Gupta V, Maple Syrup Urine D. 2022 Sep 5. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan&#8211.

  7. Blackburn PR, Gass JM, Vairo FPE, et al. Maple syrup urine disease: mechanisms and management. Appl Clin Genet. 2017;10:57–66. https://doi.org/10.2147/TACG.S125962. PMID: 28919799; PMCID: PMC5593394.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Chuang DT, Shih VE. Maple syrup urine disease (branched-chain ketoaciduria). In: Scriver CR, Beaudet A, Sly WS, Valle D, editors. The metabolic and molecular bases of inherited disease. New York, NY: McGraw-Hill; 2001. pp. 1971–2006.

    Google Scholar 

  9. Morton DH, Strauss KA, Robinson DL, et al. Diagnosis and treatment of maple syrup disease: a study of 36 patients. Pediatrics. 2002;109(6):999–1008.

    Article  PubMed  Google Scholar 

  10. De Castro-Hamoy LG, Chiong MA, Estrada SC, et al. Challenges in the management of patients with maple syrup urine disease diagnosed by newborn screening in a developing country. J Community Genet. 2017;8(1):9–15.

    Article  PubMed  Google Scholar 

  11. Medina MF, Castro G, Falcon F, et al. Maple syrup urine disease: characteristics of diagnosis and treatment in 45 patients in Chile. Am J Med Genet C Semin Med Genet. 2021;187(3):373–80.

    Article  CAS  PubMed  Google Scholar 

  12. Abi-Wardé MT, Roda C, Arnoux JB, et al. Long-term metabolic follow-up and clinical outcome of 35 patients with maple syrup urine disease. J Inherit Metab Dis. 2017;40(6):783–92.

    Article  PubMed  Google Scholar 

  13. Levin ML, Scheimann A, Lewis RA, et al. Cerebral edema in maple syrup urine disease. J Pediatr. 1993;122(1):167–8.

    Article  CAS  PubMed  Google Scholar 

  14. Carecchio M, Schneider SA, Chan H, et al. Movement disorders in adult surviving patients with maple syrup urine disease. Mov Disord. 2011;26(7):1324–8.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Frazier DM, Allgeier C, Homer C, et al. Nutrition management guideline for maple syrup urine disease: an evidence- and consensus-based approach. Mol Genet Metab. 2014;112(3):210–7.

    Article  CAS  PubMed  Google Scholar 

  16. Strauss KA, Mazariegos GV, Sindhi R, et al. Elective liver transplantation for the treatment of classical maple syrup urine disease. Am J Transpl. 2006;6(3):557–64.

    Article  CAS  Google Scholar 

  17. Ballikaya E, Yildiz Y, Koç N, et al. Oral health status of children and young adults with maple syrup urine disease in Turkey. BMC Oral Health. 2021;21(1):8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Gazit D, Zeltser R, Galili D, et al. Oral clinicopathologic manifestations in maple syrup urine disease. Oral Surg Oral Med Oral Pathol. 1989;67(6):694–7.

    Article  CAS  PubMed  Google Scholar 

  19. Peters MDJ, Godfrey C, McInerney P et al. Chapter 11: Scoping Reviews (2020 version). In: Aromataris E, Munn Z, editors. JBI Manual for Evidence Synthesis, Joanna Briggs Institute; The University of Adelaide (2020). Available online at: https://synthesismanual.jbi.global.

  20. Fukushima M, Maruta K, Senba I, et al. [Dental findings in maple syrup urine disease]. Shoni Shikagaku Zasshi. 1986;24(2):351–62. Japanese.

    CAS  PubMed  Google Scholar 

  21. Tham R, Bowatte G, Dharmage SC, et al. Breastfeeding and the risk of dental caries: a systematic review and meta-analysis. Acta Paediatr. 2015;104(467):62–84.

    Article  CAS  PubMed  Google Scholar 

  22. Tavil B, Sivri HS, Coskun T, et al. Haematological findings in children with inborn errors of metabolism. J Inherit Metab Dis. 2006;29(5):607–11.

    Article  CAS  PubMed  Google Scholar 

  23. Oelgiesser D, Levin L, Elpeleg O, et al. Posttraumatic dental implant placement in a patient with maple syrup urine disease. Implant Dent. 2006;15(2):143–7.

    Article  PubMed  Google Scholar 

  24. Anders PL, Davis EL. Oral health of patients with intellectual disabilities: a systematic review. Spec Care Dent. 2010;30:110–7.

    Article  Google Scholar 

  25. Simon E, Fingerhut R, Baumkötter J, et al. Maple syrup urine disease: favourable effect of early diagnosis by newborn screening on the neonatal course of the disease. J Inherit Metab Dis. 2006;29(4):532–7.

    Article  CAS  PubMed  Google Scholar 

  26. Sjögreen L, Mogren Å, Andersson-Norinder J, et al. Speech, eating and saliva control in rare diseases - a database study. J Oral Rehabil. 2015;42(11):819–27.

    Article  PubMed  Google Scholar 

  27. Inal Ö, Serel Arslan S, Demir N, et al. Effect of functional chewing training on tongue thrust and drooling in children with cerebral palsy: a randomised controlled trial. J Oral Rehabil. 2017;44(11):843–9.

    Article  CAS  PubMed  Google Scholar 

  28. Shah SS, Nankar MY, Bendgude VD, et al. Orofacial Myofunctional Therapy in Tongue Thrust habit: a narrative review. Int J Clin Pediatr Dent. 2021;14(2):298–303.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Kilpatrick NM, Awang H, Wilcken B, et al. The implications of phenylketonuria on oral health. Pediatr Dent. 1999;21:433–8.

    CAS  PubMed  Google Scholar 

  30. Lucas VS, Contreras A, Loukissa M, et al. Dental disease indices and caries related oral microfora in children with phenylketonuria. ASDC J Dent Child. 2001;68:263–7.

    CAS  PubMed  Google Scholar 

  31. Ballikaya E, Yildiz Y, Sivri HS, et al. Oral health status of children with phenylketonuria. J Pediatr Endocr Met. 2020;33:361–5.

    Article  Google Scholar 

  32. Hilliges C, Awiszus D, Wendel U. Intellectual performance of children with maple syrup urine disease. Eur J Pediatr. 1993;152:144–7.

    Article  CAS  PubMed  Google Scholar 

  33. Vozza I, Capasso F, Marrese E, Polimeni A, Ottolenghi L. Infant and child oral health risk status correlated to behavioral habits of parents or caregivers: a Survey in Central Italy. J Int Soc Prev Community Dent;7(2):95–9. https://doi.org/10.4103/jispcd.JISPCD_470_16.

  34. Vozza I, Cavallè E, Corridore D, Ripari F, Spota A, Brugnoletti O, Guerra F. Preventive strategies in oral health for special needs patients. Ann Stomatol (Roma). 2016;6(3–4):96–9. https://doi.org/10.11138/ads/2015.6.3.096.

    Article  PubMed  Google Scholar 

  35. Vozza I, Capasso F, Calcagnile F, Anelli A, Corridore D, Ferrara C, Ottolenghi L. School-age dental screening: oral health and eating habits. Clin Ter. 2019;170(1):e36–40. https://doi.org/10.7417/CT.2019.2105.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

Not applicable.

Author information

Authors and Affiliations

  1. Oral Medicine and Special Care Dentistry Faculty of Dentistry, Centre for Oral Diseases Studies (CODS), Al-Ahliyya Amman University, Amman, Jordan

    Yazan Hassona

  2. School of Dentistry, The University of Jordan, Amman, Jordan

    Yazan Hassona, Dua’a Alqaisi & Yara Flaifl

  3. School of Medicine, The University of Jordan, Amman, Jordan

    Asma Alkilani

Authors
  1. Yazan Hassona
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dua’a Alqaisi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yara Flaifl
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Asma Alkilani
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Y.H: case management, manuscript writing, literature reviewD.Q: case management, manuscript writing, literature reviewY.F: case management, manuscript writing, literature reviewA.K: case management, manuscript writing, literature review.

Corresponding author

Correspondence to Yazan Hassona.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent to publish

Written informed consent was obtained from patients parents for publication of this case report.

Source of fund

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hassona, Y., Alqaisi, D., Flaifl, Y. et al. The oral phenotype and dental management in patients with maple syrup urine disease; case report and scoping review. BMC Oral Health 24, 362 (2024). https://doi.org/10.1186/s12903-024-04135-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12903-024-04135-7

Keywords

BMC Oral Health

ISSN: 1472-6831

Contact us